Digital Treatment & Care - Asia

Asia

In 2024, the Digital Treatment & Care market in Asia is projected to reach a revenue of US$24.02bn.
This market is expected to show an annual growth rate (CAGR 2024-2028) of 14.52%, resulting in a projected market volume of US$41.31bn by 2028.
The user penetration in this market is expected to be 28.24% in 2024 and is projected to increase to 37.28% by 2028.
The average revenue per user (ARPU) is expected to amount to US$18.68.
In terms of global comparison, in the United States is forecasted to generate the highest revenue in the Digital Treatment & Care market, reaching US$24,240.00m in 2024.
In Japan, digital treatment and care solutions are revolutionizing the healthcare industry, providing personalized and accessible healthcare services to the aging population.

Key regions: Japan, India, United States, Canada, Italy

Definition:

The Digital Treatment & Care market includes devices and apps that help users monitor and analyze lifestyle-related aspects and improve their overall health. It includes user and revenue trends for four categories: digital care management, connected Biosensors, and online pharmacies.

Structure:

The Digital Treatment & Care market is divided into four markets:

Connected Biosensors: Biosensors that collect information on a variety of health parameters and vital signs of an individual (blood pressure, temperature, blood glucose, weight) by reading or measuring this data and transmitting it via electrical signals.

Digital Care Management: Various apps that help users monitor/detect/analyze physical health conditions. Contraception and fertility apps provide users with guidelines on self-care, family planning, and birth control, raise their awareness, and offer monitoring functions. Medication checker apps provide users with useful dosage intake guidelines, drug interaction information, and personal medication records.

Online Pharmacies: Over-the-counter medicine that can be purchased without a medical prescription through online sales channels. The market comprises analgesics, cold and cough medication, digestives and intestinal remedies, skin treatment products, and vitamins and minerals.

Digital Therapeutics (DTx): Software-based therapeutic interventions that deliver evidence-based therapeutic content to patients to prevent, manage, or treat a medical condition. DTx can be used to treat a wide range of conditions, including chronic diseases, mental health disorders, and substance use disorders.

Additional Information:

The digital care management user base includes paying and non-paying customers. The revenue figures only include revenues generated from paid apps offering premium options and from in-app purchases; revenues from app downloads and advertising are not included. The data only reflects B2C revenues; B2B and C2C revenues are not covered.

Market

Region

Region comparison

Currency

Analyst Opinion

The Digital Treatment & Care market in Asia is experiencing significant growth and development, driven by various factors such as technological advancements, increasing awareness about healthcare, and the growing adoption of digital solutions in the region.

Customer preferences: Customers in Asia are increasingly turning to digital treatment and care solutions due to their convenience, accessibility, and cost-effectiveness. The younger population, in particular, is more inclined towards using digital healthcare apps and devices for managing their health and wellness.

Trends in the market: In Japan, there is a rising demand for smart blood pressure meters and smart thermometers, driven by the country's aging population and the need for remote monitoring of health conditions. Contraception/fertility apps are also gaining popularity among young couples in urban areas who are looking for non-invasive family planning solutions.

Local special circumstances: In China, the online pharmacy sector is experiencing rapid growth, fueled by the government's support for digital healthcare initiatives and the increasing acceptance of e-commerce platforms for purchasing medications. The country's vast population and limited access to traditional healthcare facilities are also driving the demand for online pharmacy services.

Underlying macroeconomic factors: The economic growth and increasing disposable income levels in countries like South Korea and Singapore are contributing to the expansion of the digital treatment and care market. As people become more health-conscious and tech-savvy, the adoption of digital therapeutics and healthcare devices is expected to rise in these affluent Asian nations.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.

Modeling approach / Market size:

Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market segment. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.

Additional notes:

The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.